15 December 2023>: Original Paper
Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience
Masato Shizuku 123ABCDEF , Nobuhiko Kurata 1B , Kanta Jobara 1B , Yasuhiro Fujimoto 1B , Yasuhiro Ogura 1ABCDFG*DOI: 10.12659/AOT.941456
Ann Transplant 2023; 28:e941456
Figure 2 MFI changes of pDSA after liver transplantation. (A) MFI changes in pDSA class I in the rituximab (+) group. (B) MFI changes in pDSA class II in the rituximab (+) group. (C) MFI changes in pDSA class I in the rituximab (−) group. (D) MFI changes in pDSA class II in rituximab (−) group. MFI – mean fluorescence index; pDSA – preformed donor-specific antibody.